
U.S. FDA approved pimicotinib (PIMJETMI) for pts with symptomatic #TGCT in whom surgical resections could potentially worsen functional limitations or severe morbidity! Another option for patients with an unmet need for safe and effective medicines onclive.com/view/fda-approve…
















